Zenas Biopharma, Inc.
SEC CIK 1953926 · ZBIO · last insider filing 2026-06-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Moulder Leon O JR | Director · See Remarks | filed 2024 - 2026 |
| Enright Patrick G | Director | filed 2024 - 2026 |
| Allen Patricia L | Director | filed 2024 - 2026 |
| Nunn Jason Raleigh | Director | filed 2024 - 2026 |
| Orloff John J | Director | filed 2024 - 2026 |
| Lu Hongbo | Director | filed 2024 - 2026 |
| Boylan James P | Director | filed 2024 - 2026 |
| Harwin Peter Evan | Director | filed 2024 - 2026 |
| Fairmount Healthcare Fund II L.P. | Director | filed 2024 - 2026 |
| Fairmount Funds Management LLC | Director | filed 2024 - 2026 |
| Kiselak Tomas | Director | filed 2024 - 2026 |
| Xiao Ting | Director | filed 2024 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Farmer Joseph L | See Remarks | filed 2024 - 2026 |
| von Moltke Lisa | See Remarks | filed 2025 - 2026 |
| Fox Jennifer A. | See Remarks | filed 2024 - 2026 |
| Oliveira Orlando | See Remarks | filed 2024 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.